share_log

Laidlaw & Co. Initiates Coverage On SILO Pharma With Buy Rating, Announces Price Target of $10

Laidlaw & Co. Initiates Coverage On SILO Pharma With Buy Rating, Announces Price Target of $10

Laidlaw & Co.以买入评级开始对SILO Pharma进行保险,宣布目标股价为10美元
Benzinga ·  2023/08/28 04:51

Laidlaw & Co. analyst Yale Jen initiates coverage on SILO Pharma (NASDAQ:SILO) with a Buy rating and announces Price Target of $10.

Laidlaw & Co. 分析师Yale Jen以买入评级开始对SILO Pharma(纳斯达克股票代码:SILO)进行报道,并宣布目标股价为10美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发